@prefix this: <
http://purl.org/np/RAKxXSgf8ERY1j1xB8FSqCL8EeJ4swbDlnPsQ7UWTbJHs
> .
@prefix sub: <
http://purl.org/np/RAKxXSgf8ERY1j1xB8FSqCL8EeJ4swbDlnPsQ7UWTbJHs#
> .
@prefix np: <
http://www.nanopub.org/nschema#
> .
@prefix rdf: <
http://www.w3.org/1999/02/22-rdf-syntax-ns#
> .
@prefix xsd: <
http://www.w3.org/2001/XMLSchema#
> .
@prefix rdfs: <
http://www.w3.org/2000/01/rdf-schema#
> .
@prefix ns2: <
http://twoc-nlp-database-server-1:8555/solr/triples/select?q=TRIPLE_UID:
> .
@prefix ns1: <
http://wordnet-rdf.princeton.edu/lemma/
> .
@prefix prov: <
http://www.w3.org/ns/prov#
> .
@prefix ns3: <
http://twoc-nlp-database-server-1:8555/solr/triples/select?fl=TRIPLE_UID,%20CORD_UID,%20SUBJECT,%20PREDICATE,%20WORDNET_SEMREL,%20%20OBJECT,%20PRED_POSITION,%20SUBJECT_CUIS,%20OBJECT_CUIS,%20UMLS_SEMREL,%20PRED_POSITION,%20PREDICATE-LEMMA&q=CORD_UID:vbhijlmn&rows=
> .
@prefix npx: <
http://purl.org/nanopub/x/
> .
sub:Head
{
this:
np:hasAssertion
sub:assertion
;
np:hasProvenance
sub:provenance
;
np:hasPublicationInfo
sub:pubInfo
;
a
np:Nanopublication
.
}
sub:assertion
{
<
https://uts.nlm.nih.gov/uts/umls/concept/C5203670
>
ns1:suggest
<
https://uts.nlm.nih.gov/uts/umls/concept/C0149783
> .
}
sub:provenance
{
sub:assertion
prov:generatedAtTime
"2021-12-16T19:45:54.152578"^^
xsd:dateTime
;
prov:wasGeneratedBy
"S&T TWOC project version 2" .
sub:version
prov:value
2 .
rdf:OBJECT
rdfs:label
"patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" .
rdf:OBJECT-POSITION
rdfs:label
70 .
rdf:PREDICATE
rdfs:label
"suggests" .
rdf:PREDICATE-POSITION
rdfs:label
"[188]" .
rdf:SUBJECT
rdfs:label
"The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" .
rdf:SUBJECT-POSITION
rdfs:label
107 .
rdfs:ABSTRACT-UID
ns3:50
"vbhijlmn" .
rdfs:SENTENCE
rdfs:label
"The recent announcement that RECOVERY, a randomised controlled trial comparing dexamethasone to placebo in COVID-19, was terminated early due to excess deaths in the control group further suggests patients present with secondary organising pneumonia (OP) given that corticosteroid therapy is the first-line treatment." .
rdfs:TRIPLE-UID
ns2:vbhijlmn-TRIPLE-ABSTRACT-4
"vbhijlmn-TRIPLE-ABSTRACT-4" .
<
https://uts.nlm.nih.gov/uts/umls/concept/C0149783
>
rdfs:label
"corticosteroid therapy" .
<
https://uts.nlm.nih.gov/uts/umls/concept/C5203670
>
rdfs:label
"covid-19" .
}
sub:pubInfo
{
sub:assertion
prov:wasDerivedFrom
<
https://doi.org/10.1136/bmjresp-2020-000724
> .
sub:sig
npx:hasAlgorithm
"RSA" ;
npx:hasPublicKey
"MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB" ;
npx:hasSignature
"FN+7RZNxoCiq3ufK7fqkm/hx1LlXtFAwYf3fcNDiM0ZQ3d4MZuK2kf+t9+I5ZM1Mdi3UzDBL9fUF1r+Q53gWHAV3VIJ2y5Sn+KY82BcwXfp6LFxjNkEtUi11KLcQI3HM14Y6uj3CyV1khcqlmeJlp2IhUXPbS8TlkSPpHU5OdoY=" ;
npx:hasSignatureTarget
this:
.
this:
prov:generatedAtTime
"2021-12-16T19:45:54.152578"^^
xsd:dateTime
;
prov:wasAttributedTo
<
https://orcid.org/0000-0002-8954-0470
> .
}